Medtronic reported 4.1% organic revenue growth and 6.2% adjusted EPS growth. See why we upgraded MDT stock to 'Buy' with a ...
Medtronic has recalled certain Pipeline Vantage Embolization Devices with Shield Technology due to an increased risk of ...
The Food and Drug Administration has identified a Class I recall of Medtronic Neurovascular 027 Compatible Pipeline Vantage ...
Medtronic will remove one model of Pipeline Vantage devices from where they’re used and sold and will update the instructions ...
The recall, which affects two models of Pipeline Vantage embolization devices, is linked to 17 injuries and four deaths.
17h
Medical Device Network on MSNFDA tags Medtronic embolisation device recall as Class IMedtronic initiated the recall of certain Pipeline Vantage embolisation devices in January 2025 following reports of four ...
Four years into the mutually negotiated 10-year contract between Diabeter, a type 1 diabetes mellitus care-integrated ...
The stock's fall snapped a three-day winning streak.
The U.S. Food and Drug Administration on Tuesday classified the recall of Medtronic's embolization device as "most serious", following reports of the deaths of four patients. The use of the affected ...
Medtronic (MDT) stock turned lower as the FDA announced a most serious type of recall involving its Pipeline Vantage 027 ...
In a notice posted to the agency’s website, the FDA noted that on January 30, 2025, Medtronic (MDT) Neurovascular sent all affected customers ...
The FDA announced that Medtronic initiated a device recall and correction for embolization devices. The FDA has identified ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results